Walk in interview for Senior Research Fellow in NRIBAS | M.Pharm/M.Sc

National Research Institute of Basic Ayurvedic Sciences (Nehru Garden), Kothrud, Pune - 411038. is a Premier Research Institute working under the Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH. Govt. Of India, New Delhi, would like to fill up a post of Senior Research Fellow (Pharmacology/Biotechnology) on contractual/temporary basis for the ongoing IMR Project “IMR Project entitled- To Evaluate and Explore the Mechanism of Action of Anticancer Ayurvedic Plants using Cell based Assay” sponsored by C.C.R.A.S., New Delhi.

Post: Senior Research Fellow (Pharmacology/Biotechnology)

Opportunity for B.Pharm/M.Pharm/B.Sc/M.Sc as Trainee- Intern/FRESHER in SI-Insights

SI-Insights is a subsidiary company of SI Research & Solutions Pvt. Ltd. We are a market research and digital media company that transforms businesses for the digital age and helps companies in the process of decision making. We enrich our clients with critical business insights and cutting edge solutions. Our services enable clients to make confident decisions and make a competitive difference at the market place.

Post: Trainee- Intern

Build your Career in Clinical Research & Pharmacovigilance !

Welcome to the world of Opportunities !

If you have trouble viewing or submitting this form, you can fill it out online.




Build Your Career in Bangalore Pharma-IT Industry


Bangalore has shot to the top of world IT map quickly. Bangalore has more than 1500 IT, Pharma or Biotech companies (In fact, it adds 4 new IT companies every week) which employ 2.85 lakh IT professionals and still growing at more than 30% annually. On top of it, there are 20,000 biotechnology workers in the city. The IT industry has a multiplier effect on the local economy and many more are employed in support industries (transport, catering, security etc) that thrived with the upsurge in IT and BPO. Bangalore is the choice destination for more than 450 MNCs, 66 global Fortune 500 companies apart from innumerable home grown companies. The city has grown over 11% per annum over the last decade to be seen as one of the top two IT destinations in the world and virtually become a global brand.



20th Pradanya - An International Conference on Universal Health Coverage Road Map for 2020 at IIHMR University

20th Pradanya
An International Conference
on Universal Health Coverage
Road Map for 2020

October 03th - 04th 2015
Venue: Hotel Royal Orchid, Tonk Road, Jaipur

The healthcare industry today is at a crossroads and every nation in the world, faces healthcare challenges. Rich countries like the USA and Germany are battling exorbitant costs for healthcare and the long-term demographic challenges of an aging population, whereas countries like India are struggling to provide quality healthcare to millions of its people. Innovations in healthcare are emerging in India. The low cost healthcare innovations not only provide access to millions who previously could not afford the service, but also have the potential to contribute to healthcare cost containment in developed markets. Governance is both the act and/or the result of the dynamic interactions in interconnected structures which keep a domain of human activities “going”. To apply the concept of governance to the healthcare system the healthcare professionals play a vital role by bringing in different innovative strategies in the governance of healthcare. Proper governance strategies in healthcare industry are the need of the hour for Reimaging Healthcare India.

Walk in for QA, QC, Production, Packing in Ajanta Pharma, Pune

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. We are looking suitable candidates for below openings at our flagship formulation facility located at Paithan Aurangabad, which is approved by the US FDA, UK MHRA. It also holds WHO pre- qualification.

Post: Manager, Executive, Officer, Senior Officer, Assistant Manager

Walk in interview for Junior Data Analyst, Data Analyst (Pharmacovigilance) in Cognizant

Cognizant is a leading provider of information technology, consulting, and business process outsourcing services, dedicated to helping the world's leading companies build stronger businesses. Headquartered in Teaneck, New Jersey (U.S.), Cognizant combines a passion for client satisfaction, technology innovation, deep industry and business process expertise, and a global, collaborative workforce that embodies the future of work.

Post: Junior Data Analyst, Data Analyst (Pharmacovigilance)

2nd International Conference on Hepatology 2016, USA

On behalf of Hepatology 2016 Organizing Committee, we are pleased to invite Hepatologists, Gastroenterologists, Internists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons, Toxicologists, Researchers, Students, Business delegates and Young researchers across the globe to attend 2nd International Conference on Hepatology which is to be held on May 09-11, 2016 at Chicago, USA. The conference highlights the theme “To discuss and share the latest updates and cutting-edge technologies in the field of Hepatology”.



Firake Bhushan M.1, Pandagale Sagar J.2, Firke Sandip D.3, Palshikar Gautam S.4
1Department of Pharmaceutical Chemistry, JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Hadapsar, Pune
2Department of Pharmaceutical Analysis, JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Hadapsar, Pune
3Department of Pharmaceutical Chemistry, SES’s R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur
4Department of Pharmacognosy, JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Hadapsar, Pune

Epilepsy is one of the most serious disorders of the brain, affecting about 50 million people worldwide. Epilepsy leads to multiple interacting medical, psychological, economic and social consequences. Successful seizure control is very important in decreasing the psychosocial and economic costs of epilepsy. Yet, most therapies didn’t completely improve patients for numerous reasons. The most effective antiepileptic drugs (AEDs) include phenytoin, carbamazepine, valproic acid, phenobarbital, and primidone. Of the older AEDs, carbamazepine and valproic acid together bring a threat of hepatic toxicity and have been associated with fetal anomalies. Carbamazepine and phenytoin aggravate hypersensitivity reactions in a significant number of patients, and phenytoin is associated with chronic adverse events (AEs). Phenytoin, carbamazepine, phenobarbital, and primidone are hepatic enzyme inducers. Valproic acid, on the contrary, is a powerful hepatic inhibitor.

The newer agents have fewer drug interactions and slight, if at all, effect on the CYP450 enzyme system and other metabolic pathways. One of these new agents was gabapentin (GBP). GBP, the new antiepileptic drug (AED) has a broad spectrum of anti-seizure effects, less adverse effects and less drug interaction. GBP has since achieved international acknowledgment, not for its antiepileptic properties, but also its effectiveness in the managing of acute and chronic pain syndromes, especially neuropathic pain. It is prescribed as an add-on medication for the treatment of patients aged >12 years with partial and secondary generalized tonic-clonic seizures and for children aged 3 to 12 years with partial seizures. It has been used for monotherapy in adults in 38 countries. Gabapentin is regarded as safe and tolerable with a promising pharmacokinetic profile and an extensive therapeutic index.

The present article reviews the available information that dealing with the long-standing efficiency and safety of gabapentin in the treatment of patients with epilepsy.